Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome
- 1 April 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 22 (4), 509-513
- https://doi.org/10.1007/s00467-006-0377-y
Abstract
Idiopathic nephrotic syndrome is a common pediatric kidney disease, 80% of all cases are steroid sensitive (SSNS). A significant proportion of children with SSNS will have a frequently relapsing or steroid-dependent course (FRNS/SDNS) that is associated with significant treatment-related morbidity. Mutations in NPHS2 account for more than 28% of all cases of steroid-resistant nephrotic syndrome (SRNS) and dominant mutations in WT1 for 5%; while mutations are absent from children with uncomplicated SSNS. Since FRNS/SDNS is phenotypically positioned within a spectrum between SSNS and SRNS, we hypothesized that heterozygous mutations of NPHS2 may be causing FRNS/SDNS. Mutational analysis of NPHS2 and WT1 was carried out in a single-center cohort of 20 children with FRNS/SDNS, ten children with uncomplicated SSNS (control), and 22 children with SRNS (control). Renal biopsy findings were available in 15/20 children with FRNS/SDNS and revealed IgM nephropathy, MCNS, and FSGS in six, five, and four children, respectively. Children with FRNS/SDNS were significantly younger at first presentation than those with SSNS and SRNS (median age: 3.0 years in FRNS/SDNS patients, 7.0 years in SSNS patients, and 5.0 in SRNS patients; p < 0.001). No NPHS2 or WT1 mutations were found in patients with FRNS/SDNS and uncomplicated SSNS. The hypothesis that FRNS/SDNS may be associated with heterozygous mutations in NPHS2 or WT1 was not confirmed.Keywords
This publication has 17 references indexed in Scilit:
- Corticosteroid therapy for nephrotic syndrome in childrenPublished by Wiley ,2005
- Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndromeKidney International, 2004
- NPHS2 mutation analysis shows genetic heterogeneityof steroid-resistant nephrotic syndrome and lowpost-transplant recurrenceKidney International, 2004
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004
- In situ evaluation of podocin in normal and glomerular diseasesKidney International, 2003
- A Gene Mutated in Nephronophthisis and Retinitis Pigmentosa Encodes a Novel Protein, Nephroretinin, Conserved in EvolutionAmerican Journal of Human Genetics, 2002
- The Number of Podocyte Slit Diaphragms Is Decreased in Minimal Change Nephrotic SyndromePediatric Research, 2002
- Structure of the Gene for Congenital Nephrotic Syndrome of the Finnish Type (NPHS1) and Characterization of MutationsAmerican Journal of Human Genetics, 1999
- Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in childrenEuropean Journal of Pediatrics, 1993
- Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: Superiority of response to corticosteroid therapy over histopathologic patternsThe Journal of Pediatrics, 1988